DK158991C - Cholestadienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af homovitamin-d3-derivater - Google Patents

Cholestadienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af homovitamin-d3-derivater

Info

Publication number
DK158991C
DK158991C DK015390A DK15390A DK158991C DK 158991 C DK158991 C DK 158991C DK 015390 A DK015390 A DK 015390A DK 15390 A DK15390 A DK 15390A DK 158991 C DK158991 C DK 158991C
Authority
DK
Denmark
Prior art keywords
derivatives
homovitamin
chole
intermediates
stage
Prior art date
Application number
DK015390A
Other languages
English (en)
Other versions
DK15390A (da
DK15390D0 (da
DK158991B (da
Inventor
Hector F Deluca
Nobuo Ikekawa
Yoko Tanaka
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of DK15390A publication Critical patent/DK15390A/da
Publication of DK15390D0 publication Critical patent/DK15390D0/da
Publication of DK158991B publication Critical patent/DK158991B/da
Application granted granted Critical
Publication of DK158991C publication Critical patent/DK158991C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK015390A 1984-10-04 1990-01-19 Cholestadienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af homovitamin-d3-derivater DK158991C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65754984A 1984-10-04 1984-10-04
US65754984 1984-10-04
PCT/US1985/001571 WO1986002078A1 (en) 1984-10-04 1985-08-19 Vitamin d derivatives and methods for preparing same
US8501571 1985-08-19

Publications (4)

Publication Number Publication Date
DK15390A DK15390A (da) 1990-01-19
DK15390D0 DK15390D0 (da) 1990-01-19
DK158991B DK158991B (da) 1990-08-13
DK158991C true DK158991C (da) 1991-01-21

Family

ID=24637652

Family Applications (5)

Application Number Title Priority Date Filing Date
DK260086A DK154290C (da) 1984-10-04 1986-06-03 Vitamin-d-derivater og farmaceutiske praeparater indeholdende disse
DK111188A DK159389C (da) 1984-10-04 1988-03-02 Cholestadien- eller -trienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af 24-homovitamin-d3-derivater
DK177489A DK158989C (da) 1984-10-04 1989-04-13 Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater
DK015290A DK158990C (da) 1984-10-04 1990-01-19 Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater
DK015390A DK158991C (da) 1984-10-04 1990-01-19 Cholestadienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af homovitamin-d3-derivater

Family Applications Before (4)

Application Number Title Priority Date Filing Date
DK260086A DK154290C (da) 1984-10-04 1986-06-03 Vitamin-d-derivater og farmaceutiske praeparater indeholdende disse
DK111188A DK159389C (da) 1984-10-04 1988-03-02 Cholestadien- eller -trienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af 24-homovitamin-d3-derivater
DK177489A DK158989C (da) 1984-10-04 1989-04-13 Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater
DK015290A DK158990C (da) 1984-10-04 1990-01-19 Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater

Country Status (13)

Country Link
EP (1) EP0197949A1 (da)
JP (3) JPS62500301A (da)
AU (2) AU582789B2 (da)
BE (1) BE903376A (da)
CH (1) CH672920A5 (da)
DE (2) DE3590488T (da)
DK (5) DK154290C (da)
FR (1) FR2571369B1 (da)
GB (2) GB2167070B (da)
IE (1) IE58104B1 (da)
IT (1) IT1190401B (da)
NL (1) NL8520265A (da)
WO (1) WO1986002078A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0412110B1 (en) * 1988-04-21 1993-07-07 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
KR940003360B1 (ko) * 1988-04-29 1994-04-21 위스콘신 알럼나이 리써취 파운데이션 불포화 측쇄를 갖는 1α-히드록시비타민 D동족체
US5063221A (en) * 1989-04-05 1991-11-05 Chugai Seiyaku Kabushiki Kaisha Treatment for hyperparathyroidism with use of vitamin d derivatives
DE3933034A1 (de) * 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
US5891865A (en) * 1996-10-04 1999-04-06 Wisconsin Alumni Research Foundation Treatment of arthritic disease induced by infectious agents
AU2005303773A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
AU527805B2 (en) * 1978-07-27 1983-03-24 Research Institute For Medicine And Chemistry Inc. 1alpha, 1beta dihydroxy steroid-5-enes
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
US4448721A (en) * 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
CH665834A5 (de) * 1983-05-09 1988-06-15 Wisconsin Alumni Res Found Verfahren zur herstellung von 1alpha,25-dihydroxyliertem vitamin d(2) und verwandten verbindungen.

Also Published As

Publication number Publication date
DK111188A (da) 1988-03-02
DK158989B (da) 1990-08-13
DK111188D0 (da) 1988-03-02
JPH0689022B2 (ja) 1994-11-09
NL8520265A (nl) 1986-09-01
DK15390A (da) 1990-01-19
JPH0569103B2 (da) 1993-09-30
JPH05178887A (ja) 1993-07-20
DK260086A (da) 1986-06-03
IE852443L (en) 1986-04-04
WO1986002078A1 (en) 1986-04-10
GB2167070A (en) 1986-05-21
DK260086D0 (da) 1986-06-03
JPS62500301A (ja) 1987-02-05
AU582789B2 (en) 1989-04-13
DE3590488C2 (da) 1992-10-01
DK158990C (da) 1991-01-21
CH672920A5 (da) 1990-01-15
AU4776185A (en) 1986-04-17
JPH0635475B2 (ja) 1994-05-11
AU605007B2 (en) 1991-01-03
DK15290A (da) 1990-01-19
DK159389C (da) 1991-03-11
GB2167070B (en) 1988-09-01
IT8522359A0 (it) 1985-10-04
DE3590488T (de) 1986-10-09
GB2188932B (en) 1988-09-01
DK177489D0 (da) 1989-04-13
DK15390D0 (da) 1990-01-19
BE903376A (fr) 1986-02-03
DK158989C (da) 1991-01-21
DK154290C (da) 1989-03-28
GB2188932A (en) 1987-10-14
DK154290B (da) 1988-10-31
GB8524479D0 (en) 1985-11-06
FR2571369B1 (fr) 1987-12-04
DK15290D0 (da) 1990-01-19
DK177489A (da) 1989-04-13
IT1190401B (it) 1988-02-16
DK158990B (da) 1990-08-13
AU2761488A (en) 1989-06-08
GB8709579D0 (en) 1987-05-28
EP0197949A1 (en) 1986-10-22
IE58104B1 (en) 1993-06-30
DK158991B (da) 1990-08-13
DK159389B (da) 1990-10-08
FR2571369A1 (fr) 1986-04-11
JPH05222089A (ja) 1993-08-31

Similar Documents

Publication Publication Date Title
DK159146C (da) Analogifremgangsmaade til fremstilling af 1,2-diaminocyclobuten-3,4-dioner og cyclobuten-3,4-dionderivater til anvendelse som mellemprodukter i fremgangsmaaden
NO842273L (no) Fremgangsmaate ved fremstilling av aminomethyloxooxazolidinylbenzenderivater.
NO852994L (no) Fremgangsmaate ved fremstilling av glutaramidderivater.
DK161330C (da) Oxazolinoazetidinderivater til anvendelse som mellemprodukter ved fremstilling af 1-oxadethiacephalosporiner og fremgangsmaade til fremstilling af oxazolinoazetidinderivaterne
DK184588D0 (da) Mellemprodukter til brug ved fremstilling af 1alfa,25-dihydroxylerede vitamin d2-derivater
DK158991C (da) Cholestadienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af homovitamin-d3-derivater
DK505080A (da) Fremgangsmaade til fremstilling af 24,24-difluor1alfa,25-dihydroxycholecalciferol og mellemprodukter til brug ved fremgangsmaaden
DK108780A (da) Fremgangsmaade til fremstilling af urinstofderivater disses anvendelse samt mellemprodukter til anvendelse ved fremstillingen
NO160205C (no) Fremgangsmaate ved fremstilling av silibininderivater.
DK162394C (da) 26-homocholesta-5-en forbindelse, der kan anvendes som mellemprodukt til brug ved fremstillingen af 26-homovitamin d3 derivater
DK437287A (da) 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater
IT1198751B (it) Ftalocianine,loro preparazione e loro impiego come coloranti
DK157865C (da) Fremgangsmaade til fremstilling af ranitidin og ethyleniminoderivat til anvendelse som udgangsmateriale ved fremgangsmaaden
DK422582A (da) Oxiraner til anvendelse som mellemprodukter ved fremstilling af substituerede 1-azolyl-2-hydroxy-alkanderivater
DK422382A (da) Oxiraner til anvendelse som mellemprodukter ved fremstilling af substituerede 2-hydroxy-3-azolyl-propanderivater
DK513888A (da) Fremgangsmaade til fremstilling af 2-(1-halogenalkyl)thiazol-forbindelser samt hidtil ukendte forbindelser, som kan fremstilles ved fremgangsmaaden
DK382183A (da) I 6-stilling usubstituerede 7-oxo-4-oxa-diazabicyclo(3.2.0)hept-2-en-derivater, fremgangsmaader til deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af beta-lactamantibiotika
DK144698C (da) 2,4-diamino-6-halogen-5-benzylpyrimidiner til anvendelse som mellemprodukter ved fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK135885D0 (da) Mellemprodukt egnet til anvendelse ved fremstilling af terbutalinderivater
DK160987C (da) 9,10-dihydroxy-perhydroisoquinolinderivater til anvendelse som mellemprodukt ved fremstilling af 14-hydroxy-morphinanderivater
DK158347C (da) Analogifremgangsmaade til fremstilling af 1-acyl-2,3-dihydro-1h-indol-2-carboxylsyrer eller derivater deraf samt mellemprodukter til brug ved fremgangsmaaden
DK153945C (da) Alkyl-3-acyl-1,2,3,4,4a,5,10,10a-octahydro-2,5-methanobenzo(g)quinolin-3-carboxylater til brug som mellemprodukter ved fremstilling af 11(eq)-(2-acylethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazociner, samt fremgangsmaade til fremstilling af de naevnte benzazociner
DK145718C (da) Dibromforbindelse til anvendelse som mellemprodukt ved fremstilling af n-(2-amino-3,5-dibrombenzyl)-n-metylcyclohexylamin
DK155323C (da) D,1-6-oxo-4,5,6,7-tetrahydro-1h-(eller 2h)-indazol til brug som mellemprodukt ved fremstilling af tautomere aminosubstituerede 4,5,6,7-tetrahydro-1h-(eller 2h)-indazoler
DK532480A (da) 8-carboxamido eller cyano-11h-pyrido(2,1-b)-quinazolin-11-oneer til anvendelse som mellemprodukter ved fremstilling af de tilsvarende 8-tetrazol-5-ylforbindelser